Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 147 JPY -0.6% Market Closed
Market Cap: 32.8B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Daito Pharmaceutical Co Ltd stock under the Base Case scenario is 3 460.3 JPY. Compared to the current market price of 2 147 JPY, Daito Pharmaceutical Co Ltd is Undervalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
3 460.3 JPY
Undervaluation 38%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
75
Median 3Y
0.8
Median 5Y
0.9
Industry
2.5
Forward
0.7
vs History
46
vs Industry
35
Median 3Y
10
Median 5Y
10.3
Industry
21.9
Forward
12
vs History
76
vs Industry
41
Median 3Y
7.9
Median 5Y
8.6
Industry
16.5
vs History
22
vs Industry
Median 3Y
-49.3
Median 5Y
-21.4
Industry
23.6
vs History
90
vs Industry
69
Median 3Y
0.8
Median 5Y
0.8
Industry
2.1
vs History
76
vs Industry
75
Median 3Y
0.8
Median 5Y
0.9
Industry
2.6
Forward
0.7
vs History
44
vs Industry
49
Median 3Y
3.5
Median 5Y
3.9
Industry
5.2
vs History
17
vs Industry
45
Median 3Y
4.1
Median 5Y
4.6
Industry
13.3
Forward
4.5
vs History
4
vs Industry
39
Median 3Y
6.8
Median 5Y
7.4
Industry
16.6
vs History
66
vs Industry
41
Median 3Y
7.8
Median 5Y
8.2
Industry
15.6
vs History
vs Industry
Median 3Y
-25.2
Median 5Y
-24.1
Industry
19.1
vs History
88
vs Industry
71
Median 3Y
0.6
Median 5Y
0.7
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Daito Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Daito Pharmaceutical Co Ltd
TSE:4577
32.8B JPY 0.7 10.2 5.1 10.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Daito Pharmaceutical Co Ltd
TSE:4577
Average P/E: 29.6
10.2
31%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top